Dr. Touba Naim, MD

Dr. Naim practices at Saint Luke's South Hospital in Overland Park, Kansas, part of BJC Health.

Dr. Naim's NPI, 1578125530, was assigned on June 30, 2019. Dr. Naim holds Missouri license 2024029798.

Dr. Naim's primary practice is Saint Luke's South Hospital, at 12300 Metcalf Avenue, Overland Park, KS 66213 in Johnson County. The practice phone is (913) 317-7000.

Dr. Naim's primary practice is Saint Luke's South Hospital in Overland Park, Kansas, part of BJC Health. Dr. Naim is also affiliated with Saint Luke's Hospital of Kansas City. The medical group on file is Saint Luke's Medical Group. Dmand AI also links Dr. Naim to 3 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Naim practices, 5 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Naim's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dmand AI has Dr. Naim's licenses on file in 2 states: Missouri and South Dakota.

CMS data shows 960 Medicare services from Dr. Naim across 6 procedure codes in 2024, for 324 Medicare patients. Medicare paid $73,026 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 324 Medicare patients who saw Dr. Naim in 2024. The largest group is 75 to 84, with 111 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 2.49, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Naim's median patient age at 79, with 53% women.

In 2024, Dr. Naim wrote 213 Medicare Part D claims for 84 patients. 78% of them were for generic drugs. CMS names the drug for 56 of them, across 2 drugs with 11 or more claims each, at $12,295 in total drug cost. In 2022, CMS named 28 claims across 2 drugs.

Dr. Naim accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Naim, published from 2021 to 2023. Dr. Naim has published most often in S D Med. Dr. Naim's most frequent co-authors are Joseph J. Fanciullo, MD, Muhammad Hamza, MD and Dawlat Khan, MD.

CMS Open Payments shows 1 general payment to Dr. Naim from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. La Jolla Pharmaceutical Company paid the most, $115.